Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy

S Takahashi - Biological and Pharmaceutical Bulletin, 2011 - jstage.jst.go.jp
… They neutralize VEGF-A, resulting in prevention of tumor angiogenesis. VEGFR tyrosine …
tumor therapy by inhibiting VEGFR signaling. Anti-VEGF drugs are a promising therapy for …

The role of fibroblast growth factors in tumor growth

M Korc, RE Friesel - Current cancer drug targets, 2009 - ingentaconnect.com
… in designing new drug therapies to target FGF receptor (… endothelial growth factor (VEGF) to
amplify tumor angiogenesis… tumor growth and angiogenesis than targeting either factor alone…

Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy

C Timke, H Zieher, A Roth, K Hauser, KE Lipson… - Clinical cancer …, 2008 - AACR
… of radiation markedly enhanced the therapeutic efficacy in all … ) tumors growing sc on BALB/c
nu/nu mice. This study shows that radiation is an integral component of local tumor therapy

Vascular endothelial growth factor as a target for anticancer therapy

N Ferrara - The oncologist, 2004 - academic.oup.com
tumor angiogenesis are regulated by a host of growth factors … others, such as basic fibroblast
growth factor (bFGF) and the … Activating factors can be produced by the tumors themselves…

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis

DJ Hicklin, LM Ellis - Journal of clinical oncology, 2005 - ascopubs.org
… of growth factor receptor pathways that promote tumor angiogenesis. … growth factor (VEGF)
family of proteins and receptors. … with tumor progression and poor prognosis in several tumor

Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase …

JM Schlaeppi, JM Wood - Cancer and Metastasis Reviews, 1999 - Springer
… of tumor cells. In vivo, PTK787/ZK 222584 inhibited VEGFinduced angiogenesis in a growth
factor implant model as well as tumor … the subcutaneous growth of a variety of human tumor

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

HF Dvorak - Journal of clinical oncology, 2002 - ascopubs.org
… platelet-derived growth factor (PDGF) superfamily of growth factors. Other members of the
VEGF family include VEGF-B, VEGF-C, VEGF-D, and VEGF-E and placenta growth factor (PlGF…

Tumor angiogenesis and accessibility: role of vascular endothelial growth factor

RK Jain - Seminars in oncology, 2002 - Elsevier
… is the vascular endothelial growth factor (VEGF, also known as vascular permeability factor
[VPF], or … Vascular endothelial growth factor is both a vascular growth factor and a vascular …

Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy

Y Liu, Y Li, Y Wang, C Lin, D Zhang, J Chen… - Journal of Hematology & …, 2022 - Springer
therapy of the dual epidermal growth factortumor in phase II clinical trial (NCT00326495).
Secondly, aberrant expression of VEGFR and genetic alteration of fibroblast growth factor

Connective tissue growth factor–specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis

N Dornhofer, S Spong, K Bennewith, A Salim, S Klaus… - Cancer research, 2006 - AACR
… to most existing therapies. Past studies have shown that connective tissue growth factor (CTGF) …
and how CTGF influences tumor growth, we generated pancreatic tumor cell lines that …